Caprolactam Chemicals Ltd. to Approve Q4 2025 Unaudited Financial Results and Consider Dividend Payment

Caprolactam Chemicals Ltd. has announced a Board of Directors meeting on February 13, 2026, to consider and approve the unaudited financial results for the quarter ended December 31, 2025. The company will also consider recommending a dividend payment on equity shares. The trading window for all designated persons and their relatives has been closed from January 1, 2026, and will remain closed for 48 hours after the declaration of the financial results.